ArticleCanadian journal of kidney health and disease2020
Frequency, Timing, and Prediction of Major Bleeding Complications From Percutaneous Renal Biopsy.
Article in Canadian journal of kidney health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- Complication rates of 16- and 18-gauge needles for native kidney biopsies: a systematic review and proportional meta-analysis.Renal failure · 2026Pooled it
- Kidney biopsy guidebook 2020 in Japan.Clinical and experimental nephrology · 2021Guideline
- Predicting Major Bleeding in Native Kidney Biopsies: From External Validation of the Universal Bleeding Score to a New Clinical Tool.Journal of clinical medicine · 2026Article
- External Validation and Recalibration of a Risk Calculator for Major Bleeding After Diagnostic Kidney Biopsy.Kidney medicine · 2026Article
- Assessing kidney fibrosis via multiparametric MRI in native kidney and allografts.Clinical kidney journal · 2026Article
- Personalized Nursing Approaches in Monitoring and Managing Hematoma Risks After Percutaneous Renal Biopsy: A Prospective Observational Study.Journal of nursing management · 2026Observational
- What Is the Safe Observation Period Following Image-Guided Percutaneous Renal Biopsies?Journal of medical imaging and radiation oncology · 2025Article
- T1 mapping magnetic resonance imaging predicts decline of kidney function.Clinical kidney journal · 2025Article
- Ultrasound-guided kidney biopsy: a ten-year retrospective single-center experience and the promising role of clinical hypnosis.International urology and nephrology · 2025Article
- The Role of Desmopressin in Kidney Biopsies: A Narrative Review.Canadian journal of kidney health and disease · 2025Review
- Article
- Article
- Frequency and timing of renal biopsy complications.Caspian journal of internal medicine · 2024Article
- Article
- Research Letter-Outcomes of Outpatient Native Kidney Biopsies at the McGill University Health Center: A Quality Assurance Audit.Canadian journal of kidney health and disease · 2023Article
- Risk and Timing of Major Bleeding Complications Requiring Intervention of the Percutaneous Kidney Biopsy With a Short Observation Protocol: A Retrospective Chart Review.Canadian journal of kidney health and disease · 2023Article
- Surgically managed acute Page kidney following renal biopsy-A case report.International journal of surgery case reports · 2022Article
- What happens after the kidney biopsy? The findings nephrologists should know.BMC nephrology · 2022Article
- Experience and results after the implementation of a radiology day unit in a reference hospital.Insights into imaging · 2022Article
- Page kidney: an unusual complication of image-guided native renal parenchymal biopsy - case report and literature review.Radiology case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesThe risk and timing of bleeding events following ultrasound-guided percutaneous renal biopsy are not clearly defined. DESIGN SETTING PARTICIPANTS AND MEASUREMENTS: We performed a retrospective study of 617 consecutive adult patients who underwent kidney biopsy between 2012 and 2017 at a tertiary academic hospital in London, Canada. We assessed frequency and timing of minor (not requiring intervention) and major (requiring blood transfusion, surgery, or embolization) bleeds and developed a personalized risk calculator for these.
resultsBleeding occurred in 79 patients (12.8%; 95% confidence interval [CI]: 10.4%-15.7%). Minor bleeding occurred in 67 patients (10.9%; 95% CI: 8.6%-13.6%). Major bleeding occurred in 12 patients (1.9%; 95% CI: 1.1%-3.4%); 2 required embolization or surgery (0.3%; 95% CI: 0.09%-1.2%) and 10 required blood transfusion (1.6%; 95% CI: 0.9%-3.0%). Seventy-three of 79 events were identified immediately on post-procedure ultrasound (92.4% of cases; 95% CI: 84.4%-96.5%). Four of 617 patients experienced a minor event not detected immediately (0.6%; 95% CI: 0.3%-1.7%). Two patients (0.3%; 95% CI: 0.09%-1.2%) suffered a major complication that was not recognized immediately; both required blood transfusions only. There were no deaths or nephrectomies. A risk calculator using age, body mass index, platelet count, hemoglobin concentration, size of the target kidney, and whether the kidney is native, or an allograft predicted minor (C-statistic, 0.70) and major bleeding (C-statistic, 0.83).
conclusionsThis retrospective study of 617 patients who had percutaneous ultrasound-guided renal biopsies supports the safety of short post-biopsy monitoring for most patients. A risk calculator can further personalize estimates of complication risk (http://perioperativerisk.com/kbrc).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.